Showing 691-700 of 1098 results for "".
- Galderma Seeks to Address Facial Volume Loss From GLP-1 Medications with Injectable Portfoliohttps://modernaesthetics.com/news/new-datas-promising-results-to-predominant-aesthetic-concerns-for-prescription-weight-loss-medications/2473730/Galderma announced positive first results last week from a trial designed to explore the benefits of Restylane Lyft or Contour in combination with Sculptra in patients with medication-driven weight loss with associated facial volume loss. According to a press release from the manufactur
- Legal Expert Discusses Industry Outlook for 2025https://modernaesthetics.com/news/legal-expert-discusses-industry-outlook-for-2025/2473729/As a partner in the law firm Michelman & Robinson's Commercial & Business Litigation Practice, Madison Dini has a well-informed perspective on the medical industry. Among other trends, Dini expects an uptick in mergers and acquisitions (M&A) activity within medtech and aesthetics
- The Science and Art of Longevity in Aesthetics: A Panel Discussion at Octane Aesthetic Tech Forumhttps://modernaesthetics.com/news/the-science-and-art-of-longevity-in-aesthetics-a-panel-discussion-at-octane-aesthetic-tech-forum/2473727/The 2025 Octane Aesthetic Tech Forum was a two-day meeting filled with innovation, expertise, and a peek into what the future holds for the aesthetic medicine industry. After opening remarks, the forum kicked off with a panel titled “The Science and Art of Longevity in Aesthetics.”&nb
- Illuminate PRP Adds Industry Veteran Redmond as CCOhttps://modernaesthetics.com/news/illuminate-prp-adds-industry-veteran-redmond-as-cco/2473726/Industry veteran Jennifer Redmond, MBA, joined Illuminate PRP as Chief Commercial Officer, the company announced. “Jennifer brings a wealth of experience in sales and marketing within the aesthetics and pharmaceutical industries, along with strong leadership and a commitment to dr
- New Data Reveals GLP-1 Medications Impact on Medical Aesthetics Growthhttps://modernaesthetics.com/news/new-data-reveals-glp-1-medications-impact-on-medical-aesthetics-growth/2473724/Guidepoint Qsight revealed new insights Thursday on the state of the $17.5 billion medical aesthetics industry, which was up 2% in 2024. The findings highlight how the integration of glucagon-like peptide-1 (GLP-1) medications for weight loss is reshaping the aesthetics market. GLP
- SkinSpirit Medspa Expands Into Nordstromhttps://modernaesthetics.com/news/skinspirit-medspa-expands-into-nordstrom/2473725/Aesthetic treatments such as neurotoxin injections and dermal fillers will be available at Nordstrom’s flagship location in New York City through SkinSpirit, the medspa announced. SkinSpirit, which has 50 locations around the country, becomes the first medical aesthetics brand to
- Elevai Skincare Inc. Acquired by Bio-Aesthetics Company Carmellhttps://modernaesthetics.com/news/elevai-skincare-inc-acquired-by-bio-aesthetics-company-carmell/2473723/Carmell Corporation, a bio-aesthetics company focused on skin and hair health, announced in a press release that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc., to acquire the assets related
- AACS to Host Scientific Meeting Feb. 20-22 in Californiahttps://modernaesthetics.com/news/aacs-to-host-scientific-meeting-feb-20-22-in-california/2473720/The American Academy of Cosmetic Surgery (AACS) will conduct its 41st Annual Scientific Meeting (ASM) on February 20-22, 2025, with an optional pre-meeting workshop, “Sculpting Human Figure 101: The Integration of Art and Science,” on February 1
- ASDS Abstract Highlights Potential of ALA-PDThttps://modernaesthetics.com/news/asds-abstract-highlights-potential-of-ala-pdt/2473704/Photodynamic therapy (PDT) with aminolevulonic acid (ALA) was the topic of the top 10 abstract “Fine Wrinkles and the Art of Light,” presented by Luke Horton, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Horton performed a study along
- Study Backs CP-GEP Tests’ Accuracyhttps://modernaesthetics.com/news/study-backs-cp-gep-tests-accuracy/2473699/Patients with clinically node-negative primary cutaneous melanoma undergoing sentinel lymph node biopsies (SLNBs) who were classified as “high risk” according to CP-GEP tests were approximately three times more likely to be SLN positive, according to data presented October 13 at the S